Division of Teva Pharmaceutical Industries Ltd.
Latest From Immuneering Corp.
Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, and Pharmaceuticals – and then categorized by type – Acquisition, Alliance, or Financing. This month’s column covers deals announced in August 2015.
Drug Discovery Tools
- Drug Discovery Tools
- Therapeutic Areas
- Immune Disorders
- Neurology, Nervous System
- North America
- Parent & Subsidiaries
- Teva Pharmaceutical Industries Ltd.
- Senior Management
Benjamin Zeskin, PhD, CEO
Kevin D Fowler, PhD, VP, Translational Research
- Contact Info
Phone: (617) 500-8080
P.O. Box 426057 Cambridge, MA 02142-0019
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.